Castle Biosciences Inc (CSTL) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Castle Biosciences Inc   (NASDAQ: CSTL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Castle Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Castle Biosciences Inc's ROI in the second quarter of 2026?
Castle Biosciences Inc recorded a cumulative net loss of $0 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -0.04%.

Within the Healthcare sector 185 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1974 to 2343.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 5.79 % 7.82 % 9 % 13.11 % 16.67 %
Y / Y Net Income Change TTM - -88.02 % -86.56 % -36.14 % 67.42 %
Investment (TTM) in Millions 505 499 510 507 494
Return On Investment (TTM) -0.04 % 0.96 % 1.08 % 3.59 % 5.89 %
CSTL's Overall Ranking # 2343 # 1974 # 1582 # 1506 # 944
Seq. Investment Change TTM 0.54 % 1.75 % 1.44 % 1.95 % 2.47 %
Seq. Net Income Change TTM - -9.93 % -69.34 % -37.91 % -30.14 %
Net Income (TTM) in Millions 0 5 5 17 28




Return On Investment CSTL's Ranking
Within: No.
Industry # 9
Sector # 186
Overall # 2343

Return On Investment Statistics
High Average Low
42.65 %
2.01 %
-9.99 %
(Sep 30 2019)   (Jun 30 2023)







Financial Statements
Castle Biosciences Inc's II. Quarter Investments $ 505 Millions CSTL's Balance sheet
Castle Biosciences Inc's II. Quarter Income $ 0 Millions Quarterly CSTL's Income Statement
CSTL's Income by Division See CSTL's Income by Division


CSTL Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 510 482 391 399 438
Y / Y Investment Growth 5.82 % 23.14 % -1.99 % -8.78 % 5.03 %
Net Income in Millions 5 40 0 2 9
Y / Y Net Income Growth -86.55 % - - -79.75 % -
Annual Return On Investment 1.05 % 8.26 % -0.03 % 0.44 % 1.99 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 1.05 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CSTL's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CSTL's Competitors
Subscribers only: Roi for Castle Biosciences Inc's Suppliers
Subscribers only: Return On Investment for CSTL's Customers

Other Ratios
CSTL's Roa CSTL's Inventory Turnover Ratio CSTL's Growth Rates CSTL's Dividend Statistics
CSTL's Profitability Ratios CSTL's Asset Turnover Ratio CSTL's Dividend Growth
CSTL's Roe CSTL's Valuation Ratios CSTL's Financial Strength Ratios CSTL's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-13T23:38:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.